Selection of proangiogenic ascorbate derivatives and their exploitation in a novel drug-releasing system for wound healing

Wound Repair and Regeneration

Volumn 19, Issue 5, 2011, Pages 597-607

  Stumpf, Ulla ^a   Michaelis, Martin ^b,c   Klassert, Denise ^c   Cinatl, Jindrich ^b   Altrichter, Jens ^d   Windolf, Joachim ^a   Hergenröther, Julian ^d   Scholz, Martin ^a,d  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c Blue drugs GmbH   (Germany)

^d LEUKOCARE AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,2' AZINOBIS(3 ETHYLBENZOTHIAZOLINE 6 SULFONIC ACID); ASCORBIC ACID 2 PHOSPHATE; COLLAGEN; POLYETHYLENE TEREPHTHALATE; POLYURETHAN; POLYVINYL ALCOHOL; WOUND HEALING PROMOTING AGENT;

ANGIOGENESIS; ARTICLE; CELL ASSAY; CHORIOALLANTOIS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG ELUTING PLATFORM DEVICE; DRUG MECHANISM; DRUG SCREENING; ELUTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN INDUCTION; SKIN FIBROBLAST; SUSTAINED DRUG RELEASE; TUBE FORMATION ASSAY; ULTRAVIOLET RADIATION; WOUND HEALING;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ASCORBIC ACID; CELL SURVIVAL; CELLS, CULTURED; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; COLLAGEN; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; WOUND HEALING;

EID: 80052731777     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00718.x     Document Type: Article

References (32)

1. Eming SA, Krieg T, Davidson JM,. Gene transfer in tissue repair: status, challenges and future directions. Expert Opin Biol Ther 2004; 4: 1373-86. (Pubitemid 39222971)
2. Davidson JM, Krieg T, Eming SA,. Particle-mediated gene therapy of wounds. Wound Repair Regen 2000; 8: 452-9. (Pubitemid 32141449)
3. Hocking AM, Gibran NS,. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res 2010; 316: 2213-9. Epub 2010 May 13.
4. Rizzi SC, Upton Z, Bott K, Dargaville TR,. Recent advances in dermal wound healing: biomedical device approaches. Expert Rev Med Devices 2010; 7: 143-54.
5. Lansdown AB,. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol 2006; 33: 17-34. (Pubitemid 44670142)
6. Roth D, Piekarek M, Paulsson M, Christ H, Bloch W, Krieg T, Davidson JM, Eming SA,. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am J Pathol 2006; 168: 670-84. (Pubitemid 43271164)
7. Przybylski M,. A review of the current research on the role of bFGF and VEGF in angiogenesis. J Wound Care 2009; 18: 516-9.
8. Li WW, Talcott KE, Zhai AW, Kruger EA, Li VW,. The role of therapeutic angiogenesis in tissue repair and regeneration. Adv Skin Wound Care 2005; 18: 491-500.
9. Tuan TL, Song A, Chang S, Younai S, Nimni ME,. In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp Cell Res 1996; 223: 127-34. (Pubitemid 26063929)
10. Watsky MA, Weber KT, Sun Y, Postlethwaite A,. New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies. Int Rev Cell Mol Biol 2010; 282: 165-92. Epub 2010 Jun 18.
11. Nolte SV, Xu W, Rennekampff HO, Rodemann HP,. Diversity of fibroblasts-a review on implications for skin tissue engineering. Cells Tissues Organs 2008; 187: 165-76. Epub 2007 Nov 28. (Pubitemid 351398230)
12. Mitsumoto Y, Liu Z, Klip A,. A long-lasting vitamin C derivative, ascorbic acid 2-phosphate, increases myogenin gene expression and promotes differentiation in L6 muscle cells. Biochem Biophys Res Commun 1994; 199: 394-402.
13. Cinatl J, Cinatl J, Weber B, Rabenau H, Gümbel HO, Chenot JF, Scholz M, Encke A, Doerr HW,. In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate. Antiviral Res 1995; 4: 405-18.
14. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C,. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999; 26: 1231-7. (Pubitemid 29262709)
15. Michaelis M, Michaelis UR, Fleming I, Suhan T, Cinatl J, Blaheta RA, Hoffmann K, Kotchetkov R, Busse R, Nau H, Cinatl J Jr,. Valproic acid inhibits angiogenesis in vitro and in vivo. Mol Pharmacol 2004; 65: 520-7. (Pubitemid 38264019)
16. Michaelis M, Suhan S, Michaelis UR, Beek K, Rothweiler F, Tausch L, Werz O, Eikel D, Zörnig M, Nau H, Fleming I, Doerr HW, Cinatl J Jr,. Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells. Cell Death Differ 2006; 13: 446-53.
17. Michaelis M, Michaelis UR, Suhan T, Schmidt H, Mohamed A, Doerr HW, Cinatl J Jr,. Ribavirin inhibits angiogenesis by tetrahydrobiopterin depletion. FASEB J 2007; 21: 81-7. (Pubitemid 46052547)
18. Shibayama H, Hisama M, Matsuda S, Ohtsuki M, Iwaki M,. Effect of a novel ascorbic derivative, disodium isostearyl 2-O-L-ascorbyl phosphate on human dermal fibroblasts: increased collagen synthesis and inhibition of MMP-1. Biol Pharm Bull 2008; 31: 563-8. (Pubitemid 351500477)
19. Lima CC, Pereira AP, Silva JR, Oliveira LS, Resck MC, Grechi CO, Bernardes MT, Olímpio FM, Santos AM, Incerpi EK, Garcia JA,. Ascorbic acid for the healing of skin wounds in rats. Braz J Biol 2009; 69: 1195-201.
20. Collins N,. Adding vitamin C to the wound management mix. Adv Skin Wound Care 2004; 17: 109-12.
21. Boyce ST, Supp AP, Swope VB, Warden GD,. Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes. J Invest Dermatol 2002; 118: 565-72. (Pubitemid 34309974)
22. Agus DB, Vera JC, Golde DW,. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res 1999; 59: 4555-8. (Pubitemid 29428957)
23. Mayland CR, Bennett MI, Allan K,. Vitamin C deficiency in cancer patients. Palliat Med 2005; 19: 17-20. (Pubitemid 40202054)
24. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, Sanderson MJ, Bodenham A,. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996; 63: 760-5. (Pubitemid 26126597)
25. Gonzalez MJ, Miranda-Massari JR, Mora EM, Guzman A, Riordan NH, Casciari JJ, Jackson JA, Roman-Franco A,. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integrative Cancer Therapies 2005; 4: 32-44. (Pubitemid 40250676)
26. Cameron E, Pauling L, eds. Vitamin C and the immune system. In: Cancer and vitamin C, 2nd ed. Philadelphia, PA: Camino Books, 1990: 108-11.
27. Yeom CH, Lee G, Park JH, Yu J, Park S, Yi SY, Lee HR, Hong YS, Yang J, Lee S,. High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis. J Transl Med 2009; 7: 70.
28. Yeom CH, Jung GC, Song KJ,. Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration. J Korean Med Sci 2007; 22 (Suppl.): 7-11.
29. Wall IB, Moseley R, Baird DM, Kipling D, Giles P, Laffafian I, Price PE, Thomas DW, Stephens P,. Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol 2008; 128: 2526-40. Epub 2008 May 1.
30. Harding KG, Moore K, Phillips TJ,. Wound chronicity and fibroblast senescence-implications for treatment. Int Wound J 2005; 2: 364-8.
31. Berthod F, Germain L, Tremblay N, Auger FA,. Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro. J Cell Physiol 2006; 207: 491-8.
32. Sorrell JM, Baber MA, Caplan AI,. Human dermal fibroblast subpopulations; differential interactions with vascular endothelial cells in coculture: nonsoluble factors in the extracellular matrix influence interactions. Wound Rep Regen 2008; 16: 300-9. (Pubitemid 351342138)